Researchers at EMBL Barcelona, PoL-TU Dresden, and EMBL Heidelberg have identified a molecular mechanism that explains why human development unfolds more slowly than in mice and other mammals. The team discovered that across roughly 4,000 shared proteins, human cells degrade proteins at slower rates than their mouse counterparts do.
The study reveals a direct correlation between protein degradation speed and developmental pace. Matija Omazic, part of the Ebisuya Group at EMBL Barcelona, and colleagues analyzed protein turnover rates across both species using quantitative proteomics. They found this pattern holds consistently across thousands of proteins, suggesting it represents a fundamental biological principle rather than isolated exceptions.
This finding addresses a long-standing puzzle in developmental biology. Human gestation lasts nine months, childhood extends for years, and sexual maturity arrives in adolescence, while mice complete embryonic development in three weeks and reach adulthood in six to eight weeks. Despite sharing similar developmental programs and body plans, the timescales diverge dramatically. Scientists have proposed various explanations over decades, ranging from metabolic differences to regulatory gene variations. The protein degradation discovery now points to a more basic cellular mechanism driving this tempo difference.
Proteins continuously cycle through synthesis and degradation within cells. The rate at which cells break down proteins influences how quickly developmental signals accumulate, how rapidly cell fates change, and ultimately how fast developmental stages progress. Slower protein degradation in humans means developmental signals persist longer before being cleared from the system. This extends the window for each developmental stage and naturally slows the overall clock.
The Ebisuya Group studies the segmentation clock and developmental timing. Albrecht Ott and colleagues in the Savitski Team at EMBL Heidelberg specialize in protein dynamics and cellular biochemistry. Their combined expertise allowed precise measurement of protein half-lives across thousands of molecules in both species.
The research emerged from examining the molecular basis of species differences rather than assuming all mammals operate on identical cellular timescales. This comparative approach has revealed that evolutionary changes in developmental speed do not require wholesale rewiring of developmental genes. Instead, tuning the degradation machinery produces measurable tempo changes.
The implications extend beyond explaining human development. Understanding protein degradation rates could inform research into aging, disease progression, and developmental disorders. Species with faster development tend to age faster, suggesting protein degradation rates may connect developmental speed to lifespan. Conversely, disruptions in protein degradation systems contribute to conditions ranging from neurodegeneration to cancer.
Future work will likely investigate which specific degradation systems differ between species and whether evolutionary changes in protein degradation machinery drove the shift toward slower human development. The team may also examine whether accelerated or delayed development in disease states correlates with altered protein turnover rates.
This discovery transforms a nagging question about human biology into a tractable molecular problem. Rather than invoking mysterious developmental clocks, researchers can now probe the actual biochemical mechanisms regulating the pace of change.